Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(22):1599; doi:10.1093/jnci/djj486
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

NEWS

Awards, Appointments, Announcements

{blacksquare} John E. Niederhuber, M.D., was sworn in as Director of the National Cancer Institute on October 18, 2006, making him the 13th Director of the NCI in its 20-year history.

{blacksquare} Richard Leapman, Ph.D., was named scientific director of the National Institute of Biomedical Imaging and Bioengineering. Leapman previously worked for the division of bioengineering and physical science at the NIH.

{blacksquare} Moshe Yair Levy, M.D., joined the division of hematologic malignancies at the Johns Hopkins Kimmel Cancer Center in Baltimore, Md. He began working at Johns Hopkins University in 2003.

{blacksquare} Antonio Jimeno, M.D., Ph.D., joined the gastrointestinal cancer program at Johns Hopkins University. He recently completed his training in internal medicine and medical oncology at the University Hospital in Madrid.

{blacksquare} The University of Texas M.D. Anderson Cancer Center's brain tumor program, the lung cancer tissue bank at Brigham and Women's Hospital, and Gynecologic Oncology Group Tissue Bank at the Children's Hospital of Ohio State University were chosen by the NCI and the National Human Genome Research Institute for a pilot study to map the genetic changes that lead to cancer.

{blacksquare} Amander Clark, Ph.D., Hanna Mikkola, M.D., Ph.D., Kathrin Plath, Ph.D., and April Pyle, Ph.D., have joined the research team of the Institute for Stem Cell Biology and Medicine and UCLA. They are all stem cell researchers who study cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?